Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coagulation01:09

Coagulation

12.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
12.5K
Coagulation01:06

Coagulation

1.8K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.8K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

16.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
16.2K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

475
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
475
Introduction to Hemostasis01:05

Introduction to Hemostasis

19.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
19.5K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

10.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
10.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hangings: Lessons Learned from the Coroner's Office.

The Journal of surgical research·2021
Same author

Practical assessment of different saw types for field amputation: A cadaver-based study.

The American journal of emergency medicine·2021
Same author

Damage Control Laparotomy in the Cirrhotic Trauma Patient is Highly Lethal: A Matched Cohort Study.

The American surgeon·2021
Same author

Isolated traumatic brain injury: Routine intubation for Glasgow Coma Scale 7 or 8 may be harmful!

The journal of trauma and acute care surgery·2021
Same author

Retained bullet fragments after nonfatal gunshot wounds: epidemiology and outcomes.

The journal of trauma and acute care surgery·2021
Same author

Motor vehicle crashes in pregnancy: Maternal and fetal outcomes.

The journal of trauma and acute care surgery·2021
Same journal

Innovative management of Anterior Cutaneous Nerve Entrapment Syndrome (ACNES): A meta-analysis and introduction of a new robotic approach with patient-based algorithm.

American journal of surgery·2026
Same journal

Does the risk outweigh the benefit? Clot progression, recanalization & complications of anticoagulation therapy in acute pancreatitis with concomitant splanchnic vein thrombosis.

American journal of surgery·2026
Same journal

High and low body mass index and 90-day postoperative outcomes in patients with Crohn's disease undergoing abdominal surgery.

American journal of surgery·2026
Same journal

Women with firearm injuries: A multicenter mixed-methods study.

American journal of surgery·2026
Same journal

SBAS presidential address: A surgeon-scientist's journey from haptic science to digital performance metrics.

American journal of surgery·2026
Same journal

Using Dr. Google and AI to stay informed.

American journal of surgery·2026
See all related articles

Related Experiment Video

Updated: Apr 20, 2026

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

1.4K

Prothrombin complex concentrate in trauma patients.

Kazuhide Matsushima1, Elizabeth Benjamin1, Demetrios Demetriades1

  • 1Division of Acute Care Surgery, University of Southern California, 1200 North State Street, Inpatient Tower (C), Room C5L100, Los Angeles, CA 90033, USA.

American Journal of Surgery
|December 3, 2014
PubMed
Summary
This summary is machine-generated.

Prothrombin complex concentrate (PCC) shows promise for reversing Vitamin K antagonist-related coagulopathy in trauma patients. Further research is needed to determine its efficacy in massive transfusion scenarios.

Keywords:
CoagulopathyProthrombin complex concentrateTrauma

More Related Videos

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.9K
Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

22.6K

Related Experiment Videos

Last Updated: Apr 20, 2026

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

1.4K
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.9K
Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

22.6K

Area of Science:

  • Trauma Care
  • Hematology
  • Pharmacology

Background:

  • Trauma patients frequently present with coagulopathy, stemming from injury or anticoagulant use (e.g., Vitamin K antagonists).
  • Prothrombin complex concentrate (PCC), a Vitamin K-dependent coagulation factor product, has primarily been studied in non-trauma settings for coagulopathy reversal.

Purpose of the Study:

  • To review the current literature on prothrombin complex concentrate (PCC) use in trauma patients.
  • To evaluate the efficacy of PCC in reversing coagulopathy associated with Vitamin K antagonists in trauma settings.

Main Methods:

  • A comprehensive literature search was conducted across electronic databases.
  • Included studies were analyzed for PCC indications (trauma vs. non-trauma) and PCC product types (3-factor vs. 4-factor).

Main Results:

  • Small studies indicate promising outcomes for PCC in reversing Vitamin K antagonist-induced coagulopathy in trauma patients.
  • The effectiveness of PCC as an adjunct therapy in massive transfusion protocols remains under investigation.

Conclusions:

  • PCC demonstrates potential for managing Vitamin K antagonist-related coagulopathy in trauma patients.
  • Further investigation is required to establish PCC's role in massive transfusion protocols for trauma patients.